A 7-MONTH-OLD boy received an umbilical cord blood transplant for a rare genetic deficiency at a Shanghai hospital yesterday.
Doctors said it was the first case in China to be treated this way.
They said the boy suffered from leukocyte adhesion deficiency, a rare disorder which leads to low immunity and recurrent infections.
He was transferred to the Children’s Hospital of Fudan University from Wuhan in central China’s Hubei Province after treatment at a hospital there had failed.
His sister is said to have died at 5 months old because of cellulitis and severe infections.
A cord blood transplant was the best solution for the boy’s disorder, said Qian Xiaowen, director of the hospital’s hematological department.
For the full article click here
BSc (Hons) Microbiology
Biovault Family CEO, Kate Sneddon, joined Biovault in July 2009 and became Chief Executive Officer in 2016. As health industry professional her experience includes working as a microbiologist and leader at GSK for over 10 years. Her expertise in cord blood banking has been recognised in her awards, features in Parliamentary Review and Parents Guide to Cord Blood, as well as contributions to research with UCL and others.